Transcriptional pausing and stalling causes multiple clustered mutations by human activation-induced deaminase.
Transcription of the rearranged immunoglobulin gene and expression of the enzyme activation-induced deaminase (AID) are essential for somatic hypermutations of this gene during antibody maturation. While AID acts as a single-strand DNA-cytosine deaminase creating U . G mispairs that lead to mutations, the role played by transcription in this process is less clear. We have used in vitro transcription of the kan gene by the T7 RNA polymerase (RNAP) in the presence of AID and a genetic reversion assay for kanamycin-resistance to investigate the causes of multiple clustered mutations (MCMs) during somatic hypermutations. We find that, depending on transcription conditions, AID can cause single-base substitutions or MCMs. When wild-type RNAP is used for transcription at physiologically relevant concentrations of ribonucleoside triphosphates (NTPs), few MCMs are found. In contrast, slowing the rate of elongation by reducing the NTP concentration or using a mutant RNAP increases several-fold the percent of revertants containing MCMs. Arresting the elongation complexes by a quick removal of NTPs leads to formation of RNA-DNA hybrids (R-loops). Treatment of these structures with AID results in a high percentage of Kan(R) revertants with MCMs. Furthermore, selecting for transcription elongation complexes stalled near the codon that suffers mutations during acquisition of kanamycin-resistance results in an overwhelming majority of revertants with MCMs. These results show that if RNAP II pauses or stalls during transcription of immunoglobulin gene, AID is likely to promote MCMs. As changes in physiological conditions such as occurrence of certain DNA primary or secondary structures or DNA adducts are known to cause transcriptional pausing and stalling in mammalian cells, this process may cause MCMs during somatic hypermutation.
Canugovi
Chandrika
C
Department of Chemistry, Wayne State University, Detroit, Michigan 48202, USA.
Samaranayake
Mala
M
Bhagwat
Ashok S
AS
D003564:Cytidine Deaminase / Q000235:genetics / Q000378:metabolism*; D004247:DNA / Q000737:chemistry / Q000378:metabolism; D012321:DNA-Directed RNA Polymerases / Q000235:genetics / Q000502:physiology*; D004926:Escherichia coli; D005786:Gene Expression Regulation / Q000502:physiology; D006801:Humans; D007613:Kanamycin Resistance / Q000235:genetics; D009154:Mutation / Q000235:genetics*; D011815:R Factors / Q000235:genetics; D014158:Transcription, Genetic / Q000502:physiology*; D000098830:AICDA (Activation-Induced Cytidine Deaminase)
D004247:DNA; D012321:DNA-Directed RNA Polymerases; D000098830:AICDA (Activation-Induced Cytidine Deaminase); D003564:Cytidine Deaminase
Proc Natl Acad Sci U S A. 1998 Jun 9;95(12):6953-8
9618520
Biochem Soc Trans. 2006 Dec;34(Pt 6):1062-6
17073751
Eur J Immunol. 1998 Jan;28(1):317-26
9485211
Annu Rev Biochem. 2003;72:693-715
12676794
J Exp Med. 2006 Sep 4;203(9):2085-94
16894013
Proc Natl Acad Sci U S A. 1994 Feb 15;91(4):1574-8
8108447
Chem Rev. 2006 Feb;106(2):700-19
16464021
Protein Expr Purif. 1997 Feb;9(1):142-51
9116496
J Mol Biol. 2000 Jul 28;300(5):1057-65
10903854
J Immunol. 2006 Oct 15;177(8):5386-92
17015724
Nat Immunol. 2001 Jun;2(6):530-6
11376340
J Biol Chem. 1969 Jun 25;244(12):3125-32
4893337
J Exp Med. 2003 May 19;197(10):1291-6
12756266
DNA Repair (Amst). 2003 May 13;2(5):593-608
12713816
Proc Natl Acad Sci U S A. 2008 Mar 11;105(10):3843-8
18292225
EMBO J. 1992 Oct;11(10):3767-75
1396570
J Immunol. 2005 Jun 15;174(12):7787-91
15944282
J Biol Chem. 1999 Oct 22;274(43):31034-8
10521502
Mol Microbiol. 2005 Mar;55(5):1315-24
15720542
Curr Opin Immunol. 1996 Apr;8(2):206-14
8725944
Immunity. 1998 Jul;9(1):135-41
9697843
Nature. 2003 Apr 17;422(6933):726-30
12692563
Mol Cell Biol. 2005 Mar;25(5):1730-6
15713630
Mol Cell. 2004 Oct 22;16(2):163-71
15494304
Science. 2002 Jun 14;296(5575):2033-6
12065838
DNA Repair (Amst). 2007 Jun 1;6(6):689-92; author reply 693-4
17291835
Proc Natl Acad Sci U S A. 2003 Apr 1;100(7):4102-7
12651944
J Exp Med. 2007 Jan 22;204(1):181-90
17227912
Biochim Biophys Acta. 2004 Mar 15;1677(1-3):79-86
15020049
Nat Immunol. 2003 May;4(5):452-6
12692548
J Mol Biol. 1998 Sep 4;281(5):777-92
9719634
J Immunol. 2001 Apr 15;166(8):5051-7
11290786
Proc Natl Acad Sci U S A. 2005 Jan 4;102(1):75-80
15615852
Cell. 2000 Sep 1;102(5):553-63
11007474
Mol Cell Biol. 2005 Dec;25(24):10815-21
16314506
J Biol Chem. 1994 Oct 7;269(40):25120-8
7929200
J Exp Med. 1998 Aug 17;188(4):689-98
9705951
J Biol Chem. 1994 Aug 26;269(34):21850-7
8063829
Mol Cell Biol. 2006 Jun;26(11):4378-85
16705187
DNA Repair (Amst). 2007 Feb 4;6(2):235-43
17161027
Nucleic Acids Res. 2003 Jun 15;31(12):2990-4
12799424
DNA Repair (Amst). 2004 Jan 5;3(1):85-9
14697763
Science. 2003 Dec 19;302(5653):2137-40
14684824
Nat Immunol. 2003 May;4(5):442-51
12679812
Nature. 2003 Jul 3;424(6944):103-7
12819663
Immunol Rev. 1998 Apr;162:153-60
9602361
Nucleic Acids Res. 1995 Dec 25;23(24):5006-11
8559658
J Mol Biol. 2001 May 4;308(3):465-75
11327781
Mol Cell Biol. 2007 Aug;27(16):5921-32
17562862
J Biol Chem. 2003 Feb 14;278(7):4431-4
12475983
J Biol Chem. 2004 Dec 3;279(49):51612-21
15371439
Genes Dev. 2004 Jul 1;18(13):1618-29
15231739
J Biol Chem. 1972 Nov 25;247(22):7430-8
4565086
Proc Natl Acad Sci U S A. 1996 Nov 26;93(24):13919-24
8943036